Thrombin stimulates RPE cell proliferation by promoting c-Fos-mediated cyclin D1 expression

Journal of Cellular Physiology

Volumn 222, Issue 2, 2010, Pages 302-312

  Parrales, Alejandro ^a   Palma Nicolás, José Prisco ^a   López, Edith ^a   López Colomé, Ana María ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C FOS; THROMBIN; CCND1 PROTEIN, RAT; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C BETA; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR; PROTEINASE ACTIVATED RECEPTOR 1;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE TRANSLOCATION; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; ACTIVE TRANSPORT; ANIMAL; CELL CULTURE; DRUG EFFECT; DRUG POTENTIATION; EPITHELIUM CELL; GENETICS; LONG EVANS RAT; METABOLISM; PATHOLOGY; RAT; SIGNAL TRANSDUCTION; TIME; UPREGULATION; VITREORETINOPATHY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN D1; EPITHELIAL CELLS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHOLIPASE C BETA; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, LONG-EVANS; RECEPTOR, PAR-1; RETINAL PIGMENT EPITHELIUM; RNA, MESSENGER; SIGNAL TRANSDUCTION; THROMBIN; TIME FACTORS; UP-REGULATION; VITREORETINOPATHY, PROLIFERATIVE;

EID: 73349095402     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21951     Document Type: Article

References (46)

1. Aktas H, Cai H, Cooper GM. 1997. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. Mol Cell Biol 17:3850-3857.
2. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G. 1993. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 7:812-821.
3. Blagosklonny MV, Pardee AB. 2002. The restriction point of the cell cycle. Cell Cycle 1:103-110.
4. Brunet A, Roux D, Lenormand P, Dowd S, Keyse S, Pouyssegur J. 1999. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J 18:664-674.
5. Chang L, Karin M. 2001. Mammalian MAP kinase signalling cascades. Nature 410:37-40.
6. Chang CW, Roque RS, Defoe DM, Caldwell RB. 1991. An improved method for isolation and culture of pigment epithelial cells from rat retina. Curr Eye Res 10:1081-1086.
7. Chen CY, Ezzeddine N, Shyu AB. 2008. Messenger RNAhalf-life measurements in mammalian cells. Methods Enzymol 448:335-357.
8. Daub H, Wallasch C, Lankenau A, Herrlich A, Ullrich A. 1997. Signal characteristics of G protein-transactivated EGF receptor. EMBO J 16:7032-7044.
9. Ellis CA, Malik AB, Gilchrist A, Hamm H, Sandoval R, Voyno-Yasenetskaya T, Tiruppathi C. 1999. Thrombin induces proteinase-activated receptor-1 gene expression in endothelial cells via activation of Gi-linked Ras/mitogen- activated protein kinase pathway. J Biol Chem 274:13718-13727.
10. Frank J. 2000. The ribosome - A macromolecular machine par excellence. Chem Biol 7:R133-R141.
11. Gutierrez-Venegas G, Castillo-Aleman R. 2008. Characterization of the transduction pathway involved in c-fos and c-jun expression induced by Aggregatibacter actinomycetemcomitans lipopolysaccharides in human gingival fibroblasts. Int Immunopharmacol 8:1513-1523.
12. Hecquet C, Lefevre G, Valtink M, Engelmann K, Mascarelli F. 2002. Activation and role of MAP kinase-dependent pathways in retinal pigment epithelial cells: ERK and RPE cell proliferation. Invest Ophthalmol Vis Sci 43:3091-3098.
13. Higuchi R, Dollinger G, Walsh PS, Griffith R. 1992. Simultaneous amplification and detection of specific DNA sequences. Biotechnology (NY) 10:413-417.
14. Jones SM, Kazlauskas A. 2001. Growth-factor-dependent mitogenesis requires two distinct phases of signalling. Nat Cell Biol 3:165-172.
15. Katso R, Okkenhaug K, Ahmadi K, White S, Timms J, Waterfield MD. 2001. Cellular function of phosphoinositide 3-kinases: Implications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol 17:615-675.
16. Keenan SM, Lents NH, Baldassare JJ. 2004. Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression. J Biol Chem 279:5387-5396.
17. Kong D, Yamori T. 2008. Phosphatidylinositol 3-kinase inhibitors: Promising drug candidates for cancer therapy. Cancer Sci 99:1734-1740.
18. Lavoie JN, L'Allemain G, Brunet A, Muller R, Pouyssegur J. 1996. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem 271:20608-20616.
19. Leopoldt D, Hanck T, Exner T, Maier U, Wetzker R, Nurnberg B. 1998. Gbetagamma stimulates phosphoinositide 3-kinase-gamma by direct interactionwith two domains of the catalytic p110 subunit. J Biol Chem 273:7024-7029.
20. Li H, Weinstein IB. 2006. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells. Cancer Res 66:11399-11408.
21. Liang J, Slingerland JM. 2003. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2:339-345.
22. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R. 2001. Proteinase-activated receptors. Pharmacol Rev 53:245-282.
23. Mund M, Rodrigues M. 2006. The retinal pigment epithelium. In: Zinn K, Marmar M, editors. The retinal pigment epithelium. London: Harvard University Press. pp 45-52.
24. Murphy LO, Smith S, Chen RH, Fingar DC, Blenis J. 2002. Molecular interpretation of ERK signal duration by immediate early gene products. Nat Cell Biol 4:556-564.
25. Musgrove EA. 2006. Cyclins: Roles in mitogenic signaling and oncogenic transformation. Growth Factors 24:13-19.
26. Nagasaki H, Shinagawa K, Mochizuki M. 1998. Risk factors for proliferative vitreoretinopathy. Prog Retin Eye Res 17:77-98.
27. Nicole O, Goldshmidt A, Hamill CE, Sorensen SD, Sastre A, Lyuboslavsky P, Hepler JR, McKeon RJ, Traynelis SF. 2005. Activation of protease-activated receptor-1 triggers astrogliosis after brain injury. J Neurosci 25:4319-4329.
28. Palma-Nicolas JP, Lopez E, Lopez-Colome AM. 2008. PKCisoenzymes differentially modulate he effect of thrombin on MAPK-dependent RPE proliferation. Biosci Rep 28:307-317.
29. Pastor JC, de la Rua ER, Martin F. 2002. Proliferative vitreoretinopathy: Risk factors and pathobiology. Prog Retin Eye Res 21:127-144.
30. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH. 2001. Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocr Rev 22:153-183.
31. Puro DG, Mano T, Chan CC, Fukuda M, Shimada H. 1990. Thrombin stimulates the proliferation of human retinal glial cells. Graefes Arch Clin Exp Ophthalmol 228:169-173.
32. Qiu RG, Chen J, McCormick F, Symons M. 1995. A role for Rho in Ras transformation. Proc Natl Acad Sci USA 92:11781-11785.
33. Rao HV, Thirumangalakudi L, Desmond P, Grammas P. 2007. Cyclin D1, cdk4, and Bim are involved in thrombin-induced apoptosis in cultured cortical neurons. J Neurochem 101:498-505.
34. Resendiz JC, Kroll MH, Lassila R. 2007. Protease-activated receptor-induced Akt activation-regulation and possible function. J Thromb Haemost 5:2484-2493.
35. Schwartz GK, Shah MA. 2005. Targeting the cell cycle: A new approach to cancer therapy. J Clin Oncol 23:9408-9421.
36. Shaulian E, Karin M. 2001. AP-1 in cell proliferation and survival. Oncogene 20:2390-2400.
37. Soh JW, Lee EH, Prywes R, Weinstein IB. 1999. Novel roles of specific isoforms of protein kinase C in activation of the c-fos serum response element. Mol Cell Biol 19:1313-1324.
38. Strauss O. 2005. The retinal pigment epithelium in visual function. Physiol Rev 85:845-881.
39. Treinies I, Paterson HF, Hooper S, Wilson R, Marshall CJ. 1999. Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal To stimulate DNA synthesis. Mol Cell Biol 19:321-329.
40. Trejo J. 2003. Protease-activated receptors: New concepts in regulation of G proteincoupled receptor signaling and trafficking. J Pharmacol Exp Ther 307:437-442.
41. Villalonga P, Ridley AJ. 2006. Rho GTPases and cell cycle control. Growth Factors 24:159-164.
42. Weber JD, Raben DM, Phillips PJ, Baldassare JJ. 1997. Sustained activation of extracellularsignal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. Biochem J 326:61-68.
43. Xi G, Reiser G, Keep RF. 2003. The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: Deleterious or protective? J Neurochem 84:3-9.
44. Yang K, Hitomi M, Stacey DW. 2006. Variations in cyclin D1 levels through the cell cycle determine the proliferative fate of a cell. Cell Div 1:32.
45. Yu K, Ma P, Ge J, Willey CD, Yang P, Wang Z, Gao Q. 2007. Expression of protein kinase C isoforms in cultured human retinal pigment epithelial cells. Graefes Arch Clin Exp Ophthalmol 245:993-999.
46. Zenz R, Eferl R, Scheinecker C, Redlich K, Smolen J, Schonthaler HB, Kenner L, Tschachler E, Wagner EF. 2008. Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease. Arthritis Res Ther 10:201.